# Immunotherapy for Elderly Patients With Chronic Osteoporotic Pain

> **NCT04524169** · PHASE4 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Osteoporotic Pain

## Interventions

- **DRUG:** Thymosin Alpha1

## Key facts

- **NCT ID:** NCT04524169
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04524169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04524169, "Immunotherapy for Elderly Patients With Chronic Osteoporotic Pain". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04524169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
